Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
brucellosis
MeSH D002006 - brucellosis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D016905:
Gram-negative bacterial infections
29 Companies
14 Drugs
$
Success rate
D002006:
Brucellosis
13 Companies
4 Drugs
$
Success rate
D002007:
Bovine brucellosis
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
0
%
0/0
Phase 2
0
%
0/0
Phase 3
100
%
2/2
Approved:
2
Overall Success rate:
0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Mylan
Rifampin
Sanofi
Isoniazid
,
Pyrazinamide
,
Rifampin
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use